allogenic hepatocytes
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 20, 2021 (NCT04806581)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06306781 | N/A | Mar 30, 2024 | Jiao Tong University |
| NCT04496479 | Phase 2 | Nov 15, 2021 | LyGenesis |
| NCT04806581 | Phase 1 | Apr 20, 2021 | Jiao Tong University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiao Tong University | Academic/Hospital | 2 | 2 | 2 | 2021 |
| LyGenesis | For profit | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1